Literature DB >> 314491

Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen.

L J Rosenwasser, C A Dinarello, A S Rosenthal.   

Abstract

A macrophage-dependent, antigen-specific murine T-cell proliferation assay was utilized to examine the role of soluble products of murine and human adherent cells in the activation of T lymphocytes. Highly purified human leukocytic pyrogen, and supernates from both murine and human mononuclear phagocytes-macrophages stimulated the immune T-cell proliferative response to the multideterminant antigens dinitrophenyl-ovalbumin and keyhole limpet hemocyanin. The implications of these studies and the relationship of leukocytic pyrogen to human lymphocyte-activating factor are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314491      PMCID: PMC2185642          DOI: 10.1084/jem.150.3.709

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Lymphocyte-activating factor. I. Generation and physicochemical characterization.

Authors:  J S Economou; H S Shin
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

3.  Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

Authors:  S B Mizel; J J Oppenheim; D L Rosentreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

4.  Purification and properties of human lymphocyte activating factor (LAF).

Authors:  G Blyden; R E Handschumacher
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

5.  Human leukocytic pyrogen: purification and development of a radioimmunoassay.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

6.  Adherent cell function in murine T lymphocyte antigen recognition. II. Definition of genetically restricted and nonrestricted macrophage functions in T cell proliferation.

Authors:  L J Rosenwasser; A S Rosenthal
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

7.  Secretion of mediators following T lymphocyte-macrophage interaction is regulated by the major histocompatibility complex.

Authors:  A G Farr; M E Dorf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

8.  Adherent cell function in murine T lymphocyte antigen recognition. I. A. macrophage-dependent T cell proliferation assay in the mouse.

Authors:  L J Rosenwasser; A S Rosenthal
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

9.  Spontaneous pyrogen production by mouse histiocytic and myelomonocytic tumor cell lines in vitro.

Authors:  P Bodel
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Studies on artifical antigens. I. Antigenicity of DNP-polylysine and DNP copolymer of lysine and glutamic acid in guinea pigs.

Authors:  F S KANTOR; A OJEDA; B BENCARERRAF
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

View more
  56 in total

Review 1.  Cytokines: past, present, and future.

Authors:  J J Oppenheim
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 2.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 3.  Historical insights into cytokines.

Authors:  Charles A Dinarello
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

4.  Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.

Authors:  Jan Tavernier; Sarah Gerlo; Bram Van Den Eeckhout; Lien Van Hoecke; Elianne Burg; Sandra Van Lint; Frank Peelman; Niko Kley; Gilles Uzé; Xavier Saelens
Journal:  NPJ Vaccines       Date:  2020-07-23       Impact factor: 7.344

5.  Interleukin-1 production in acute viral hepatitis.

Authors:  C Müller; I Gödl; R Ahmad; H M Wolf; J W Mannhalter; M M Eibl
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

6.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Immunodeficiency with defective T-cell response to interleukin 1.

Authors:  E T Chu; L J Rosenwasser; C A Dinarello; F S Rosen; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Demonstration of interleukin 1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen.

Authors:  D F Hanson; P A Murphy
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes.

Authors:  E Kownatzki; A Kapp; S Uhrich
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Studies on the active site of human leukocytic pyrogen.

Authors:  C A Dinarello; K Bendtzen; S M Wolff
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.